MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: Directa Plus notes second Graphene Plus trial in Oxford

ALN

Directa Plus PLC - graphene nanoplatelets supplier - Notes that Oxfordshire County Council is starting its second trial of a patented asphalt concrete modifier developed by Iterchemica and enhanced by Graphene Plus.

The new trial will see two stretches of Marsh Lane in Oxford resurfaced with different materials, one with GiPave and the other with conventional asphalt to be compared.

‘This new trial follows a number of successful trials and pilot schemes in the UK and Italy with the product now gaining considerable traction in construction markets. GiPave is yet another product launching into commercial markets containing our Graphene Plus, a pure form of graphene produced through a sustainable process which is certified safe for humans and the environment,’ says Chief Executive Officer Giulio Cesareo.

Current stock price: 97.00 pence, down 12%

12-month change: down 18%

Copyright 2022 Alliance News Limited. All Rights Reserved.